Neuland Laboratories Limited (NSE:NEULANDLAB)
India · Delayed Price · Currency is INR 19,955
-245 (-1.21%)
Oct 15, 2026, 3:29 PM IST
Neuland Laboratories Market Cap
Neuland Laboratories has a market cap or net worth of 255.86 billion as of October 15, 2026. Its market cap has increased by 22.41% in one year.
Market Cap
255.86B
Enterprise Value
258.11B
Revenue
23.72B
Global Rank
n/a
Country Rank
n/a
PE Ratio
51.40
ChartMarket Cap Chart
Since December 18, 2000, Neuland Laboratories's market cap has increased from 335.14M to 255.86B, an increase of 76,245.48%. That is a compound annual growth rate of 29.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 255.86B | 31.29% |
| Dec 31, 2025 | 194.89B | 10.65% |
| Dec 31, 2024 | 176.13B | 159.63% |
| Dec 29, 2023 | 67.84B | 216.90% |
| Dec 30, 2022 | 21.41B | 7.77% |
| Dec 31, 2021 | 19.86B | 41.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gland Pharma | 506.78B |
| Ipca Laboratories | 485.36B |
| Ajanta Pharma | 419.71B |
| Emcure Pharmaceuticals | 348.25B |
| Wockhardt | 316.76B |
| Piramal Pharma | 258.45B |
| Cohance Lifesciences | 175.98B |
| Alivus Life Sciences | 164.47B |